AstraZeneca SG&A Expense (Quarterly) Trends | YCharts

AstraZeneca PLC (AZN)

181.36 +2.40 (+1.34%) USD | NYSE | Jun 11, 11:52

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for AZN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (Quarterly) Chart

Start Trial

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2000. Start Trial.

Date	Value
March 31, 2026	140.76M
December 31, 2025	152.78M
September 30, 2025	147.08M
June 30, 2025	144.69M
March 31, 2025	135.52M
December 31, 2024	141.67M
September 30, 2024	145.00M
June 30, 2024	132.00M
March 31, 2024	135.00M
December 31, 2023	145.00M
September 30, 2023	129.00M
June 30, 2023	131.00M
March 31, 2023	134.00M
December 31, 2022	156.00M
September 30, 2022	126.00M
June 30, 2022	129.00M
March 31, 2022	125.00M
December 31, 2021	124.00M
September 30, 2021	120.00M
June 30, 2021	103.00M
March 31, 2021	99.00M
December 31, 2020	109.00M
September 30, 2020	99.00M
June 30, 2020	104.00M
March 31, 2020	87.00M

Date	Value
December 31, 2019	92.00M
September 30, 2019	88.00M
June 30, 2019	81.00M
March 31, 2019	78.00M
December 31, 2018	93.00M
September 30, 2018	73.00M
June 30, 2018	84.00M
March 31, 2018	81.00M
December 31, 2017	85.00M
September 30, 2017	76.00M
June 30, 2017	72.00M
March 31, 2017	77.00M
December 31, 2016	83.00M
September 30, 2016	76.00M
June 30, 2016	91.00M
March 31, 2016	76.00M
December 31, 2015	99.00M
September 30, 2015	79.00M
June 30, 2015	84.00M
March 31, 2015	77.00M
December 31, 2014	88.00M
September 30, 2014	87.00M
June 30, 2014	77.00M
March 31, 2014	72.00M
December 31, 2013	2.770B

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks

Start Trial

GSK Plc	2.855B
Johnson & Johnson	6.034B
Eli Lilly & Co.	2.934B
Merck & Co., Inc.	2.70B
Novo Nordisk A/S	2.070B